The aim of this study is to explore recreational ketamine users' experiences of ketamine bladder syndrome (KBS) and related health care provision issues. KBS is an emerging condition caused by chronic, recreational ketamine use, which can result in extensive, irreparable damage to the bladder and urinary tract. However, little is yet known about how patients are personally affected by the condition, their help seeking behaviour or experiences of related health care services. A qualitative study, informed by Heideggerian hermeneutics was undertaken. Twelve participants affected by KBS were purposively recruited into the study from an National Health Service (NHS) continence service and a drug support agency in South Wales, UK. Data were collected through recorded, semi-structured interviews and analysed using a three-step approach. Participants were predominantly younger, poly-drug users and typically developed KBS following prolonged, habitual ketamine use. The effects of KBS were considerable and included incontinence, haematuria, profound abdominal pain and embarrassment and were exacerbated by delays in help seeking, disjointed medical care and on-going ketamine use, which was integral to the self-management of KBS pain. KBS has significant impact on those affected and can result in extensive, irreversible damage to the bladder and urinary tract. The condition, and its management, is further compounded by chronic poly-drug use, chaotic lifestyles and a range of complex, related co-morbidities, which require a collaborative, multi-disciplinary approach. Anderson's behavioural model of health services use provides an appropriate framework for better understanding help seeking/ avoidance behaviour in this cohort, which can help inform clinical practice.
To inform this study, a comprehensive literature review was undertaken using CINAHL, MEDLINE and PsychINFO databases. The following search terms were used, in various combinations: ketamine, bladder, syndrome, KBS, urinary, ulcerative and cystitis. Papers published in English were sought, no date restrictions were applied. From around 2007 onwards, there is an emerging programme of research in this area, although most relevant literature is in the form of medical case studies, reviews and discussion papers, which primarily highlight symptom effects and treatment challenges. No studies were found that specifically explored the personal experiences of those affected by KBS.
Consequently, little is yet known about how patients are affected by KBS, their understanding of the condition, motivations for seeking help or their experiences of related health care services. An in-depth understanding of these complex issues could therefore help to inform related clinical practice. This study was subsequently undertaken to explore these multifaceted issues.
| METHODOLOGY

| Aim
To explore recreational ketamine users' experiences of KBS and related health care provision issues.
| Methodology
To better understand participants' experiences, a qualitative approach, informed by Heideggerian hermeneutics, was used. The methodology is interpretative and is therefore appropriate in helping to uncover common meanings in narratives and to comprehend situational contexts. 6 The methodology allows participants to reflect on and describe their experiences and social practices, in depth, through "naturalistic conservations," which help to reflect their lived experiences. 7, 8 
| Sample and recruitment
Participants were purposively recruited into the study in SpringAutumn 2013 from a regional NHS continence service and a community-based drug support agency in South Wales, UK. Participants were identified, approached and recruited into the study by gatekeepers in each organization, using an agreed inclusion/ exclusion criteria, which were developed in consultation with both centres. Respondents were invited to participate if they were adults, ketamine users, experiencing KBS and able to provide informed consent. Respondents were not invited to participate if they were legal minors, unable to provide informed consent, diagnosed with other bladder problems (eg, pre-existing bladder problems and/or other urological conditions, not related to ketamine use) or unaware of their condition.
Suitable participants were provided with a participant information pack, which included a covering letter, participant information leaflet, expression of interest (EOI) form and freepost envelope. Those interested in the study completed an EOI form and returned it to the research team. The project research assistant (RA), who was not involved in their treatment or care, then contacted prospective participants to discuss the study in more detail, answer any questions and, if appropriate, arranged to meet. On meeting, the RA ensured they met the inclusion criteria and, if they were happy to participate, written consent was obtained prior to data collection.
Twelve participants (seven men, five women) were recruited into the study. Participants' mean age was 26 years (age range
What is known about this topic 
What this paper adds
• Initial KBS symptoms are normalized due to their progressive nature and commonality amongst other ketamine users, which results in delayed help seeking, exacerbates disease progression and further complicates patient management.
• While ketamine cessation is essential, due to tolerance, dependence and pain management issues, users are unlikely to achieve this alone and will therefore require further specialist support to abstain.
• Given the association with poly-drug dependence, chronic bladder problems and other related co-morbidities, KBS should be regarded as a core component of a more complex whole, the management of which requires an integrated, multidisciplinary approach. 20-43 years). At the time of recruitment, all were poly-drug users, most were unemployed, one was in part-time training, one was selfemployed and two were employed part-time. Further participant demographics are presented in Table 1 :
| Data collection
Data were collected through semi-structured interviews, which were conducted in private by the RA, at the drug support agency premises.
Interviews lasted 30 to 60 minutes. The interview schedule was devised following a review of the literature and in discussion with gatekeepers at both recruiting organizations.
Consistent with the espoused methodology, interview questions
were open and provided a framework for discussion, while allowing participants to talk freely about their experiences of ketamine use, KBS and associated health care provision issues. To obtain an in-depth understanding of participants' experiences, several techniques were used during the interview, as and where appropriate, including probing, clarifying, restating and summarizing. 9 To establish appropriateness, the interview schedule was piloted on the first three participants recruited. The schedule was found to be appropriate and not amended. All pilot data were therefore incorporated into the main study findings.
| Data analysis
Interviews were digitally recorded, transcribed verbatim and analysed using Linsdeth and Norberg 10 three-step approach, which involves naive reading, structural analysis and comprehensive understanding.
In the first step (naive reading), interviews were listened to and interview transcripts were read and re-read with an "open mind" to establish a sense of the collective data and to inform the next analysis stage. In the structural analysis phase, initial sub-themes and, subsequently, themes were identified and formulated that conveyed a sense of participants' experience. 9 The final phase (comprehensive understanding) involved an in-depth interpretation of the data and reflection, revision and reconsideration of the themes identified during the analytical process. 9 Data analysis was led by two researchers (C.S. and P.G.) but all phases were discussed critically within the research team, to further facilitate interpretation of the data. Data analysis was managed using Nvivo10 (QSR International, Melbourne, Australia). 
| Ethics
| FINDINGS
Four key themes were identified from analysis of the data:
• Ketamine use and associated bladder symptoms
• Pain experience and pain management
• The psychosocial impact of KBS
• Health care service experiences
| Ketamine use and associated bladder symptoms
Most participants were introduced to ketamine in their teens by an older relative (eg, brother) or friend and, at the time of initiation, were already poly-drug users. Ketamine was primarily snorted as a powder and generally consumed socially with friends. All maintained that they were initially unaware of the potentially adverse effects of ketamine on the bladder. However, as tolerance and dependence gradually increased, ketamine was used more frequently (often daily) and in increasingly higher doses, to gain the desired dissociative effect. Consequently, most participants developed noticeable KBS symptoms within around 6 to 24 months of this change in use.
Common KBS symptoms included bladder storage or voiding problems, frequency, nocturia, urgency, hesitancy, urinating with interrupted flow, leakage, voiding small volumes of urine and, in many, urge incontinence often occurred if they could not reach a toilet in time. Most symptoms were unpredictable, interchangeable, embarrassing and distressing. However, as they were insidious and common amongst other users, they became "an acceptable norm." Nonetheless, some symptoms were more serious and of far greater concern. For example, urinary retention, requiring catheterisation and, eventually, intermittent self-catheterisation:
I was going a lot more, but when I was going, I wasn't passing much and really bad burning and blood in my urine. Then just before my 18th birthday I was admitted because I couldn't go to the toilet anymore. F108
One of the latter KBS symptoms was haematuria, which was initially infrequent and relatively minor but gradually increased significantly, causing considerable concern:
When I first noticed, I didn't think nothing of it because it wasn't hurting. It was just little strings of blood and then it was like just blood, there weren't no urine in it … It would be like clots, like pure blood … Within about six months, it was like nothing you've ever seen… Every time I was weeing, it looked like a murder scene in my toilet. M106
| Pain experience and pain management
One of the most progressive, profound KBS symptoms was pain, which was exacerbated by regular ketamine use. Pain was commonly experienced in the abdomen, supra-pubic, lower back and/or genital regions and was particularly severe when needing to urinate and/or when urinating. While the nature and intensity often varied, KBS pain was described as intense, cramping and was often unbearable:
It felt like my vagina was on fire… like I was being torn apart. It got that excruciating my mum took me to hospital. I was in that much pain I was screaming... tell them to get some pain relief. They were trying to ask me questions and I couldn't answer because I was in absolute agony, it was worse than childbirth... it felt like somebody was slicing me open. F105
Most participants lived with severe, chronic, debilitating pain, which was extremely difficult to manage, as most prescribed analgesia, including Tramadol, provided inadequate pain relief:
There's not much you can do about it, painkillers wouldn't work, nothing would work, because the pain was like I've never experienced. M112
Participants felt that most health professionals did not fully appreciate the severity of their pain, although they acknowledged that their chronic substance misuse probably affected General Practitioners (GP's) analgesic prescribing practices. Consequently, selfmedication was common:
These last few days I've been taking stupid drugs that 
| Health care service experiences
Participants were initially reluctant to seek medical help, as preliminary KBS symptoms were "normalized." Feelings of embarrassment and self-loathing were common and compounded by the fear of being stigmatized. The social nature of ketamine use also commonly resulted in "friend of a friend stories" about painful, embarrassing medical procedures, which were off-putting. Some participants were also concerned that worsening symptoms were indicative of terminal illness:
I was scared, I thought I was dying. I thought I was peeing out organs. I was too afraid to go to the Doctors in case he was going to tell me I had cancer, you're dying. I didn't want to know that, I'd rather not know and not have those worries. M106
The eventual triggers for seeking help were worsening symptoms (particularly incontinence, severe pain and haematuria) and pressure from family and friends. GP's were generally the first point of contact, although subsequent A&E visits, following episodes of severe pain and/or heavy bleeding were common. However, during these initial consultations, not only were they not asked about ketamine use, despite presenting symptoms, but they also did not routinely volunteer such information, because they were too embarrassed to do so. Even when they eventually did disclose ketamine use to their GP, the significance of such information was apparently not acknowledged.
Misdiagnosis (eg, urinary tract infections [UTIs]) and repeated, unnecessary courses of antibiotics were therefore common and compounded the belief that GPs had a very limited understanding of KBS.
It was only when symptoms did not resolve that participants were eventually referred to a urologist and subsequently diagnosed with KBS. Participants were commonly advised that, while no curative treatment was available, symptoms would probably eventually resolve if they stopped using ketamine. While this advice was considered appropriate, in and of itself, it was considered unhelpful, as participants required further dedicated help and support to quit:
There needs to be specialist knowledge about drug misuse and you should be signposted straight away. 
| Complexity of KBS and chronic substance misuse
Several factors related to chronic substance misuse compound the complexity of KBS and its management. Most chronic ketamine users are young poly-drug users. 2, 4, 23 While existing research indicates that habitual ketamine use causes KBS, 13 it is possible that the condition and/or many of the associated problems are related to, or exacerbated by, poly-drug use.
KBS pain is severe and very difficult to manage. However, because of chronic substance misuse problems, anecdotal evidence suggests that GP's are reluctant to prescribe opiates. Self-medication is therefore common, which is associated with significant risks, such as adverse side-effects and over-dosage. Ketamine is also instrumental in pain self-management because of its short-term effectiveness.
However, this practice not only causes further, potentially irreversible damage to the bladder and urinary tract but it also makes ketamine cessation extremely difficult. Furthermore, because of its dissociative effects, users commonly limit the potential for harm by consuming ketamine with other users, which results in the development of close drug-related friendships. 24, 25 Consequently, these social networks further complicate ketamine cessation and probably compound feelings of hopelessness.
| Assessment and management of patients with KBS
It is estimated that around 20% to 30% of chronic ketamine users will experience lower urinary tract symptoms (LUTS), 4 
| Help seeking and avoidance
Delays in seeking medical attention can adversely affect disease progression and the development of more complex co-morbidities, which are usually more difficult and costly to treat. Identifying factors that affect help-seeking behaviour can therefore help to inform the development of appropriate interventions that may promote expeditious access to relevant health care services. However, while help avoidance is common in KBS, particularly in the early stages, when the condition is potentially reversible, a meaningful rationale for this behaviour has not yet been adequately explicated.
This study indicates that several factors inform help-seeking/ avoidance behaviour. The wider, related urinary incontinence and substance misuse literature, also respectively offer additional, constructive insights into these complex issues. Furthermore, Andersen's behavioural model of health services use 34 provides an expedient framework for better understanding the fundamental components that commonly inform help avoidance/seeking in health care. The model was originally developed in 1968 (and has since undergone several iterations) to facilitate understanding of how relevant health care services are accessed and/or used. 35 It has subsequently been applied extensively many health care studies, including related substance misuse 36 and urological research and was therefore considered appropriate for this patient population. Andersen 34 proposes that several key Numerous enabling/inhibiting factors also inform this process.
The emotional impact of KBS is considerable. Consequently, as demonstrated within the wider, related literature, feelings such as embarrassment, self-loathing and fear of being stigmatized are known to be significant barriers to help seeking. 14, 23, 37, 39 The perception that ketamine is a "horse tranquiliser" 40 may further exacerbate help avoidance because of concerns about particularly "deviant behaviour." Synonymous with the wider substance misuse literature, unemployment and disorganized lifestyles are common and known to adversely affect help seeking and health care engagement. 36, 41 However, the multifaceted nature of KBS, related to the inextricable amalgamation of ketamine/poly-drug dependence and chronic bladder symptoms, probably further compound this problem. Furthermore, given the prevalence of additional, related co-morbidities in poly-drug users, including potential mental health problems, help seeking is likely to be further complicated in this cohort. Finally, due to chaotic lifestyles and apparent social isolation, access to meaningful social support, which is integral to help seeking, is limited. However, subsequent pressure from family and friends, as a result of ongoing, worsening symptoms, appears to be a key help-seeking facilitator.
Establishing treatment necessity generally involves appraisal of several issues, such as symptom severity, perceived health risk, treatment effectiveness beliefs and readiness for treatment. 14, 42 However, mild KBS symptoms are normalized and tolerated, probably because of their insidious nature and commonality amongst fellow ketamine users. Help avoidance is therefore common, when symptoms are regarded as inconsequential. 14, 23, 39 36 although, given the nature of this qualitative study, these issues are beyond the scope of this research. The application of Andersen's model is therefore not intended to provide a definitive exposition of these complex issues, but rather, it merely offers health professionals a useful framework for comprehending the complexities associated with help seeking, avoidance and engagement, which can subsequently help to inform clinical practice. In particular, it can help to facilitate the development of appropriate strategies to reduce and/or prevent harm, moderate help seeking obstacles and promote expedient approaches to patient management.
Given the limited understanding of KBS amongst many health professionals, especially GPs, there is a need to raise awareness of the condition and approaches to management, through dissemination and training, so that clinicians are better able to treat and support patients.
Effective harm prevention/reduction strategies are also required to better inform existing (and prospective) users about the harmful effects of chronic ketamine use. Information provision should emphasize the particularly undesirable effects of KBS, such as incontinence, haematuria and pain, which users are likely to find disconcerting. To help promote timely engagement with health care services, drug support agencies in particular, need to highlight the potential reversibility of symptoms when identified early.
Management of KBS should largely focus on minimizing bladder damage through appropriate assessment, timely referral and abstinence from ketamine use. Health professionals should therefore ask patients presenting with severe, persistent and unresponsive LUTS about ketamine use 3, 19, 29, 43 in an appropriate, sensitive manner. This routine practice may also help to reduce embarrassment or stigma associated with ketamine use.
As KBS is inextricably associated with poly-drug dependence, chronic bladder problems and a range of multifaceted, related co-morbidities, the condition should be considered as part of a more complex whole, the management of which is beyond any one professional group. Instead, a collaborative, multidisciplinary approach is required, which involves nurses, GPs, urologists, pain and drug support teams.
There is also a need for greater liaison between health and social care services 4 to ensure a more integrated approach to the management of those with such complex needs. Clearly, the most important aspect of KBS management is early ketamine cessation and this must therefore be the key message that health professionals convey to patients. 1, 5 However, because of its social nature, analgesic function and dependency issues, health professionals should acknowledge that KBS patients will require further specialist help and support to facilitate ketamine abstinence, as they are unlikely to achieve this by their own volition.
Drug support agencies are best placed to advise in the management of drug dependency. However, findings suggest that substance misuse regimens are likely to be complex and costly, due to tolerance, dependence and ongoing poly-drug use and, therefore, to be effective, may even require removing the user from their current social net-
work. An effective approach to pain management is also essential to help minimize the likelihood of continued ketamine use (and/or other drugs) for pain self-management. There is therefore a need for pain teams to advise nurses, GPs and urologists about appropriate pain management. Engaging poly-drug users in health care services is, however, an ongoing, obstinate problem and devising meaningful strategies to promote engagement remains a significant challenge that requires further work.
This study has also highlighted several areas in need of further research that could further help inform practice and policy. These include the need for:
• Accurate epidemiological data to establish the nature and extent of chronic ketamine use and KBS.
• Research that better informs understanding of KBS aetiology and/or factors that may exacerbate disease progression.
• Research that explores the perspectives of health professionals involved in treating this patient group, to better understand the challenges associated with KBS management.
| Study limitations
While this study provides a novel, in-depth insight into participants' experiences of KBS, there are several limitations associated with this research. Due to the size and nature of the sample, findings may not be representative of the wider KBS, or chronic ketamine user, population. During data collection, it was also apparent that some participants struggled with particular recall issues, such as ketamine dose/ frequency specificity. Consequently, the veracity of aspects of some accounts is perhaps questionable. It is also important to recognize that all participants were poly-drug users. Many of the issues raised, may not therefore be due to ketamine alone, but are perhaps instead related to the effects of chronic poly-substance misuse and/or other underlying co-morbidities.
| CONCLUSION
This study demonstrates that KBS has a profound impact on those affected, commonly resulting in significant and potentially irreversible damage to the bladder and urinary tract. The condition is further compounded by ketamine and poly-drug dependence, related comorbidities and delays in help seeking, which further complicate patient management. Findings from this study also suggest that
Anderson's behavioural model of health services use 34 provides a relevant framework for understanding help seeking/avoidance behaviour in this patient population, which can help inform clinical practice and related research.
However, in the absence of a curative treatment, management of KBS, requires a multidisciplinary approach, which focuses on promoting timely health care access, specialist referral and providing appropriate assistance to facilitate ketamine abstinence.
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